WHO

Six NGOs present recommendations for Moscow WHO forum on non-communicable diseases

Six NGOs, including Knowledge Ecology International (KEI), Medecins Sans Frontieres (MSF), Oxfam, Third World Network (TWN), Universities Allied for Essential Medicines (UAEM), and Young Professionals Chronic Disease Network (YP-CDN), recently submitted recommendations to Member States to control non-communicable diseases (NCDs) in low- and middle-income countries in advance of the Moscow Ministerial conference.

A PDF of the joint statement with logos of the groups is available here:
http://keionline.org/sites/default/files/ncd-6healthngos-moscow.pdf

KEI presentation to the WHO Consultive Expert Working Group on R&D

Attached below are two PDF files that were used in my presentation today at the 1st meeting of the World Health Organization (WHO). I did not following the text that closely. The WHO is making a video of all of the presentations, which will be made available later.

Response of WHO to KEI letter regarding McKinsey, vaccine policy and competing interests

On 20 February 2011, Dr. Keiji Fukuda, Assistant Director-General - Health Security and Environment, World Health Organization, responded to KEI's letter (16 February 2011) regarding McKinsey, vaccine policy and competing interests. Here is the response in full (email contacts have been redacted).

From: "Fukuda, Keiji"
Date: February 20, 2011 4:14:05 PM GMT+01:00
To: "Thiru Balasubramaniam"

KEI letter to WHO regarding McKinsey, vaccine policy and competing interests

On 15 February 2011, the Co-Chairs of the WHO Open-Ended Working Group of Member States on Pandemic Influenza Preparedness: sharing of influenza viruses and access to vaccines and other benefits (OEWG) held a consultation with civil society. The Co-chairs of the OEWG are Ambassador J. Gomez-Camacho, Mexico and Ambassador B. Angell-Hansen, Norway.

Noncommunicable diseases in the 2011 global public health agenda

Noncommunicable diseases (NCDs) enjoy a place of prominence on the global public health agenda in 2011. At the 128th WHO EB, the assembly was abuzz with news of a joint Russian and WHO initiative, the "First global ministerial conference on healthy lifestyles and noncommunicable disease control" to be held in Moscow on 28-29 April 2011 and the UN High-level Meeting of the General Assembly on Non-Communicable Diseases in September 2011.

Le Monde: L’OMS face à un nouveau conflit d’intérêts

The following is an article by Agathe Duparc which appeared on page four of the Sunday/Monday edition (23 January-24 January 2011) of Le Monde with a reference on the cover page. Below the article are two paragraphs providing readers with more background information on the World Health Assembly and the Executive Board. The third paragraph is the main quote highlighted in the print version. What is missing in this copy below is a cartoon accompanying the piece which shows a bespectacled man with a body of an octopus holding two syringes in a field of dollar signs.

Response to Mary Moran on managing conflicts of interest at the WHO CEWG

This is a response to an email message posted to a2k and ip-health by Dr. Mary Moran. Among other things, the missive raises the issue of what constitutes a conflict of interest, and also how such conflicts should be managed. Dr. Moran has asked for a response, and this is it.

Dear Dr. Moran,

WHO Executive Board accepts appointment of Herrling to Consultative Expert Working Group on R&D

After several days of negotiations, the 128th WHO Executive Board has accepted the nomination of Paul Herrling to the new WHO Consultative Expert Working Group on R&D Financing, despite the fact that Herrling is an executive of Novartis, and is the author of the IFPMA/Novartis/FRIND proposal and the co-author of the PDP Plus proposal, which will be considered by the CEWG.

Nine civil society groups write WHO Executive Board about conflict of interest on WHO R&D Financing group

On January 20, 2011, 9 civil society organizations sent a letter to the WHO Executive Board registering an objection to the selection of Dr. Paul Herrling of Novartis to the WHO Consultative Expert Working Group on Research and Development: Financing and Coordination. The groups signing the letter were:

  • CIDEPRO
  • Déclaration de Berne - Berne Declaration
  • HAI Europe
  • HAI Global
  • Health GAP (Global Access Project)
Syndicate content